
Keywords: Prostate cancer; BRD BET bromodomain and extra-terminal domain; BRD BET inhibitor; Chromatin structure remodeling; Transcriptional co-activator; Androgen receptor; TF; transcription factor; HAT; histone acetyltransferase; HDAC; histone deacetylase; BRD; b